Legal status · United Kingdom
Is Melanotan I legal in the United Kingdom?
Yes. Melanotan I is an approved medicine in the United Kingdom, classified as "Licensed (EU/UK) for erythropoietic protoporphyria". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.
Melanotan I in the United Kingdom at a glance
| Classification | Licensed (EU/UK) for erythropoietic protoporphyria |
|---|---|
| MHRA approval status | Approved by MHRA for its labeled use |
| Evidence level | Strong (research strength: Strong) |
| Reviewed | Sep 2026 |
Classification and note come from the Melanotan I profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.
What this means
- 01
MHRA has approved Melanotan I for at least one labeled indication, so a pharmaceutical-grade product exists in the United Kingdom and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Melanotan I is
An FDA-approved melanocortin agonist that increases skin pigmentation to protect people with a rare light-sensitivity disorder.
Melanotan I, or afamelanotide, is a melanocortin receptor agonist approved by the FDA in 2019 as Scenesse. It is used to increase pain-free light exposure in adults with erythropoietic protoporphyria, a rare inherited condition of severe skin light sensitivity, by stimulating protective pigmentation.
Mechanism: Agonizes the melanocortin-1 receptor to stimulate eumelanin production, increasing photoprotective skin pigmentation.
Regulatory history: FDA-approved (Scenesse) for erythropoietic protoporphyria
How MHRA treats this kind of product
Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.
The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Melanotan I at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Melanotan I in other countries
United States
Approved medicineFDA-approved for a specific indication, prescription only
Is Melanotan I legal in the United States?Australia
Approved medicineTGA-registered for erythropoietic protoporphyria
Is Melanotan I legal in Australia?Canada
Approved medicineApproved for erythropoietic protoporphyria
Is Melanotan I legal in Canada?Frequently asked questions
Is Melanotan I legal in the United Kingdom?
Yes. Melanotan I is an approved medicine in the United Kingdom, classified as "Licensed (EU/UK) for erythropoietic protoporphyria". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.
Can I buy Melanotan I in the United Kingdom?
Only with a prescription. Melanotan I is classified as "Licensed (EU/UK) for erythropoietic protoporphyria" in the United Kingdom, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.
Is Melanotan I MHRA approved?
Yes, for its labeled indication. In the United Kingdom Melanotan I is classified as "Licensed (EU/UK) for erythropoietic protoporphyria". For comparison, the US FDA status is: FDA-approved (Scenesse) for erythropoietic protoporphyria. Evidence level: Strong.
Related compounds in the United Kingdom
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Melanotan I live on its compound profile.
Melanotan I profileThis page is general information about the regulatory status of Melanotan I in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.